- Home
- BMY vs HCA Comparison
BMY vs HCA Comparison
Compare BMY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- HCA
- Stock Information
- Founded
- BMY 1887
- HCA 1968
- Country
- BMY United States
- HCA United States
- Employees
- BMY N/A
- HCA N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- HCA Hospital/Nursing Management
- Sector
- BMY Health Care
- HCA Health Care
- Exchange
- BMY Nasdaq
- HCA Nasdaq
- Market Cap
- BMY 110.2B
- HCA 93.8B
- IPO Year
- BMY N/A
- HCA N/A
- Fundamental
- Price
- BMY $58.21
- HCA $335.05
- Analyst Decision
- BMY Hold
- HCA Buy
- Analyst Count
- BMY 14
- HCA 17
- Target Price
- BMY $53.92
- HCA $374.06
- AVG Volume (30 Days)
- BMY 11.9M
- HCA 1.7M
- Earning Date
- BMY 10-31-2024
- HCA 10-25-2024
- Dividend Yield
- BMY 4.11%
- HCA 0.79%
- EPS Growth
- BMY N/A
- HCA 9.31
- EPS
- BMY N/A
- HCA 22.31
- Revenue
- BMY $47,435,000,000.00
- HCA $69,621,000,000.00
- Revenue This Year
- BMY $6.54
- HCA $9.76
- Revenue Next Year
- BMY N/A
- HCA $6.13
- P/E Ratio
- BMY N/A
- HCA $15.02
- Revenue Growth
- BMY 5.56
- HCA 10.23
- 52 Week Low
- BMY $39.35
- HCA $245.84
- 52 Week High
- BMY $61.08
- HCA $417.14
- Technical
- Relative Strength Index (RSI)
- BMY 61.07
- HCA 28.92
- Support Level
- BMY $55.82
- HCA $345.83
- Resistance Level
- BMY $59.73
- HCA $360.18
- Average True Range (ATR)
- BMY 1.67
- HCA 8.20
- MACD
- BMY 0.11
- HCA -1.76
- Stochastic Oscillator
- BMY 61.84
- HCA 11.69
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.